PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,000 | -76.1% | 15,000 | -76.9% | 0.01% | -76.2% |
| Q4 2020 | $218,000 | -21.9% | 65,000 | -18.2% | 0.04% | 0.0% |
| Q3 2020 | $279,000 | -21.2% | 79,470 | +3.2% | 0.04% | -40.8% |
| Q2 2020 | $354,000 | -0.6% | 76,970 | -28.5% | 0.07% | -52.0% |
| Q1 2020 | $356,000 | -38.2% | 107,577 | +14.0% | 0.15% | -7.5% |
| Q4 2019 | $576,000 | +10.8% | 94,351 | -24.4% | 0.16% | -42.9% |
| Q3 2019 | $520,000 | -52.2% | 124,788 | +50.5% | 0.28% | -79.5% |
| Q2 2019 | $1,088,000 | – | 82,931 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
| NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
| Platform Technology Partners | 251,723 | $657,000 | 0.29% |
| DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
| Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
| Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
| Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
| RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
| New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
| XTX Topco Ltd | 15,574 | $41,000 | 0.02% |